surmount-1 trial tirzepatide non-diabetic weight loss for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled Tirzepatide for the treatment of

Some strategies that help include timing your injection to precede your socially challenging days (inject Wednesday if weekends are your struggle), planning lighter meals specifically for days 5 through 7, and discussing split dosing with your provider to maintain more consistent levels

Here is how to handle them without derailing your progress

HbA1c Reduction: - 2.4% in type 2 diabetes patients (SURPASS-2 trial)

A high-quality protein supplement can also help maintain protein targets when appetite is reduced

Your kitchen counter or bathroom vanity works fine

Older adults benefit tremendously from tirzepatide but might need additional interventions to address loose skin or optimize body composition